Implication of JAK1, JAK2, and JAK3 in the Realization of Proliferation and Differentiation Potential of Mesenchymal Progenitor Cells In Vitro


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Involvement of individual JAK kinases in the realization of growth potential of mesenchymal progenitor cells was examined in vitro. Important role of JAK2 and JAK3 in determining the initial level of mitotic activity of progenitor cells was established. The yield of fibroblast CFUF was suppressed under the effect of specific inhibitors of JAK kinases. Blockade of JAK3 increased the rate of progenitor element differentiation. JAK1 had no effect on proliferation and differentiation status of progenitor cells.

Sobre autores

G. Zyuz’kov

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine; National Research Tomsk State University

Autor responsável pela correspondência
Email: zgn@pharm.tsu.ru
Rússia, Tomsk; Tomsk

V. Zhdanov

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

E. Udut

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

L. Miroshnichenko

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

E. Simanina

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

T. Polyakova

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

A. Chaikovskii

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

L. Stavrova

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

V. Udut

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine; National Research Tomsk State University

Email: zgn@pharm.tsu.ru
Rússia, Tomsk; Tomsk

V. Agafonov

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

Ya. Burmina

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

M. Danilets

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

M. Minakova

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

A. Dygai

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk


Declaração de direitos autorais © Springer Science+Business Media New York, 2016

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies